Clinical Trials in Egypt / NCT07154186
Recruiting
Observational
Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients
NCT07154186 · tracked via the Priya Life Science Egypt tracker
Condition(s) studied
Triglycerides Glucose IndexAngiographic ProfilingNon-DiabeticPrematureCoronary Artery Disease
Investigational drug(s) / intervention(s)
Coronary Angiographic Assessment
Coronary Angiographic Assessment: Coronary angiographic assessment will be performed for all patients.
Study summary
This study aims to evaluate the impact of the triglyceride-glucose (TyG) index on the angiographic profiling of non-diabetic patients with premature coronary artery disease (CAD).
Eligibility
Inclusion Criteria:
* Age ≥18 years old.
* Both sexes.
* Non-diabetic patients \[no history of diabetes, hemoglobin A1C (HbA1C) \< 6.5%, fasting glucose \< 126 mg/dL\].
* Confirmed diagnosis of coronary artery disease (CAD) by coronary angiography.
Exclusion Criteria:
* Known diabetes mellitus (type 1 or type 2).
* Previous history of coronary revascularization.
* Severe hepatic or renal dysfunction \[alanine transaminase (ALT)/aspartate aminotransferase (AST) ≥ 5× upper limit of normal (ULN), estimated glomerular filtration rate (eGFR)\< 30 mL/min/1.73 m²\].
* Malignant disease, autoimmune disease, or systemic inflammatory disorders.
* Current use of triglyceride-lowering medications.
Primary outcome measure(s)
- Incidence of ischemia- driven revascularization — 6 months post-procedure
Incidence of ischemia- driven revascularization will be recorded.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Sohag University | Sohag | Egypt | Recruiting |
More Sohag University trials in Egypt
Other trials for the same condition
Prognostic Nutritional Index for Predicting Outcomes Following Coronary Artery Bypass Grafting (CABG) Surgery
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07154186 on ClinicalTrials.gov ↗ ← All trials in Egypt